BioCentury | May 31, 2019
Financial News

May 31 Financial Quick Takes: Mabpharm prices Hong Kong IPO; plus follow-ons from Amicus, Myovant and more

...FDA in 4Q19 for relugolix (TAK-385) to treat uterine fibroids. Zhejiang DTRM Biopharma planning overseas listing Zhejiang DTRM Biopharma Co. Ltd....
...is in Phase Ib testing in China. Brian Moy, Assistant Editor DTRM-12, DTRMWXHS-12 Amicus Therapeutics Inc. Mabpharm Ltd. Myovant Sciences Ltd. Zhejiang DTRM Biopharma Co. Ltd. Zhejiang...
BioCentury | Apr 25, 2019
Finance

The academic founders' conundrum

...Cowin Capital Group , Korea Investment Partners , Elite Capital Ph II Cardiovascular 2011 Zhejiang DTRM Biopharma Co. Ltd....
BioCentury | Jan 5, 2018
Financial News

DTRM Biopharma closes series A round

...Zhejiang DTRM Biopharma Co. Ltd. (Zhejiang, China) raised a series A round on Jan. 2 worth more...
...lymphocytic leukemia (CLL), and is being tested as monotherapy and in combinations. Zhejiang DTRM Biopharma Co. Ltd., Zhejiang, China Allison Johnson DTRM-12 Zhejiang DTRM Biopharma Co. Ltd. Bruton's...
BioCentury | Jan 2, 2018
Financial News

DTRM Biopharma raises series A round

...Zhejiang DTRM Biopharma Co. Ltd. (Zhejiang, China) raised a series A round worth more than $60 million...
...lymphoma and chronic lymphocytic leukemia (CLL), and is being tested as monotherapy and in combinations. Allison Johnson DTRM-12 Zhejiang DTRM Biopharma Co. Ltd. Bruton's...
BioCentury | Dec 9, 2017
Product Development

Multimodal meeting

...automated system CD19-positive cancer relapsed after allo-SCT Engraftment and expansion in first 2 patients 1993 Zhejiang DTRM Biopharma Co. Ltd....
Items per page:
1 - 5 of 5
BioCentury | May 31, 2019
Financial News

May 31 Financial Quick Takes: Mabpharm prices Hong Kong IPO; plus follow-ons from Amicus, Myovant and more

...FDA in 4Q19 for relugolix (TAK-385) to treat uterine fibroids. Zhejiang DTRM Biopharma planning overseas listing Zhejiang DTRM Biopharma Co. Ltd....
...is in Phase Ib testing in China. Brian Moy, Assistant Editor DTRM-12, DTRMWXHS-12 Amicus Therapeutics Inc. Mabpharm Ltd. Myovant Sciences Ltd. Zhejiang DTRM Biopharma Co. Ltd. Zhejiang...
BioCentury | Apr 25, 2019
Finance

The academic founders' conundrum

...Cowin Capital Group , Korea Investment Partners , Elite Capital Ph II Cardiovascular 2011 Zhejiang DTRM Biopharma Co. Ltd....
BioCentury | Jan 5, 2018
Financial News

DTRM Biopharma closes series A round

...Zhejiang DTRM Biopharma Co. Ltd. (Zhejiang, China) raised a series A round on Jan. 2 worth more...
...lymphocytic leukemia (CLL), and is being tested as monotherapy and in combinations. Zhejiang DTRM Biopharma Co. Ltd., Zhejiang, China Allison Johnson DTRM-12 Zhejiang DTRM Biopharma Co. Ltd. Bruton's...
BioCentury | Jan 2, 2018
Financial News

DTRM Biopharma raises series A round

...Zhejiang DTRM Biopharma Co. Ltd. (Zhejiang, China) raised a series A round worth more than $60 million...
...lymphoma and chronic lymphocytic leukemia (CLL), and is being tested as monotherapy and in combinations. Allison Johnson DTRM-12 Zhejiang DTRM Biopharma Co. Ltd. Bruton's...
BioCentury | Dec 9, 2017
Product Development

Multimodal meeting

...automated system CD19-positive cancer relapsed after allo-SCT Engraftment and expansion in first 2 patients 1993 Zhejiang DTRM Biopharma Co. Ltd....
Items per page:
1 - 5 of 5